Evar trial nejm

A: The primary safety outcomes were symptomatic intracranial hemorrhage detected on neuroimaging within 3 days after the initiation of treatment and mortality at 90 days.

Mortality at 90 days was The risk of symptomatic intracranial hemorrhage within 3 days after the initiation of treatment was 4.

Rotation Prep. Learning Lab. Resident Lounge. Student Corner. Log In. Log in via Email. Forgot your password? Notably, there were significantly fewer aneurysm-related deaths in the endovascular group compared to the no intervention group adjusted HR 0. This difference was driven by significant reductions in mortality in the 6 month to 4 year period following repair adjusted HR 0. In total, graft-related complications and 66 graft-related interventions were observed during the trial, and these rates were comparable to the rates observed in the EVAR I trial.

All rights reserved. No works may be reproduced without written consent from 2minutemedicine. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism.

No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. Register now to get free full access to over searchable archived reports, visual abstracts, Classics Series landmark trials, weekly rewinds, and much more. Remember Me. Login Register. Home The Classics Surgery Classics.

June 23, Share on Facebook Share on Twitter. Image: PD 1. Determining the absolute risk of rupture among growing intracranial aneurysms. Endovascular interventions appear superior to surgery in treatment of blister-like aneurysms. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. Register now to get free full access to over searchable archived reports, visual abstracts, Classics Series landmark trials, weekly rewinds, and much more.

Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians.

Join numerous brands, companies, and hospitals who trust our licensed content. Remember Me. Login Register. Home The Classics Surgery Classics.

June 23, Share on Facebook Share on Twitter. Image: PD 1. The EVAR I trial compared the safety and efficacy of endovascular and open abdominal aortic aneurysm repair 2. Dual anti-platelet therapy before a coronary artery bypass grafting procedure not associated in difference in postoperative outcomes.

Related Reports. Weekly Rewinds. Dual anti-platelet therapy before a coronary artery bypass grafting procedure not associated in difference in postoperative outcomes January 3, Severity of functional mitral regurgitation on admission predicts long-term risk of rehospitalization and death December 27,